Adverum Biotechnologies (ADVM) Competitors $3.09 +0.05 (+1.68%) As of 11:12 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADVM vs. SGMT, SOPH, AARD, FENC, TLSA, GALT, ALEC, TVRD, MNPR, and CRGXShould you be buying Adverum Biotechnologies stock or one of its competitors? The main competitors of Adverum Biotechnologies include Sagimet Biosciences (SGMT), SOPHiA GENETICS (SOPH), Aardvark Therapeutics (AARD), Adherex Technologies (FENC), Tiziana Life Sciences (TLSA), Galectin Therapeutics (GALT), Alector (ALEC), Tvardi Therapeutics (TVRD), Monopar Therapeutics (MNPR), and CARGO Therapeutics (CRGX). These companies are all part of the "pharmaceutical products" industry. Adverum Biotechnologies vs. Its Competitors Sagimet Biosciences SOPHiA GENETICS Aardvark Therapeutics Adherex Technologies Tiziana Life Sciences Galectin Therapeutics Alector Tvardi Therapeutics Monopar Therapeutics CARGO Therapeutics Sagimet Biosciences (NASDAQ:SGMT) and Adverum Biotechnologies (NASDAQ:ADVM) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership. Which has better earnings and valuation, SGMT or ADVM? Sagimet Biosciences has higher revenue and earnings than Adverum Biotechnologies. Sagimet Biosciences is trading at a lower price-to-earnings ratio than Adverum Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSagimet Biosciences$2M123.17-$45.57M-$1.83-4.14Adverum Biotechnologies$1M64.85-$130.93M-$7.85-0.39 Is SGMT or ADVM more profitable? Sagimet Biosciences' return on equity of -39.88% beat Adverum Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets Sagimet BiosciencesN/A -39.88% -38.40% Adverum Biotechnologies N/A -297.29%-101.40% Which has more risk & volatility, SGMT or ADVM? Sagimet Biosciences has a beta of 3.37, suggesting that its share price is 237% more volatile than the S&P 500. Comparatively, Adverum Biotechnologies has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Do insiders and institutionals hold more shares of SGMT or ADVM? 87.9% of Sagimet Biosciences shares are held by institutional investors. Comparatively, 48.2% of Adverum Biotechnologies shares are held by institutional investors. 14.7% of Sagimet Biosciences shares are held by company insiders. Comparatively, 6.0% of Adverum Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer SGMT or ADVM? Sagimet Biosciences presently has a consensus target price of $25.67, suggesting a potential upside of 238.83%. Adverum Biotechnologies has a consensus target price of $19.75, suggesting a potential upside of 538.95%. Given Adverum Biotechnologies' higher possible upside, analysts clearly believe Adverum Biotechnologies is more favorable than Sagimet Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sagimet Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Adverum Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media favor SGMT or ADVM? In the previous week, Sagimet Biosciences had 2 more articles in the media than Adverum Biotechnologies. MarketBeat recorded 3 mentions for Sagimet Biosciences and 1 mentions for Adverum Biotechnologies. Sagimet Biosciences' average media sentiment score of 0.48 beat Adverum Biotechnologies' score of 0.44 indicating that Sagimet Biosciences is being referred to more favorably in the media. Company Overall Sentiment Sagimet Biosciences Neutral Adverum Biotechnologies Neutral SummarySagimet Biosciences beats Adverum Biotechnologies on 13 of the 15 factors compared between the two stocks. Get Adverum Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADVM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADVM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADVM vs. The Competition Export to ExcelMetricAdverum BiotechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$65.14M$3.08B$5.75B$9.82BDividend YieldN/A2.26%3.95%4.02%P/E Ratio-0.4021.1830.8726.51Price / Sales64.85394.02464.97121.10Price / CashN/A44.4437.7659.36Price / Book-3.228.1410.186.69Net Income-$130.93M-$54.08M$3.27B$265.51M7 Day Performance5.49%2.97%2.95%3.35%1 Month Performance16.64%4.09%4.16%1.00%1 Year Performance-55.33%19.11%45.06%23.48% Adverum Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADVMAdverum Biotechnologies3.9194 of 5 stars$3.09+1.7%$19.75+539.0%-58.0%$65.14M$1M-0.40190SGMTSagimet Biosciences2.9814 of 5 stars$7.55-1.6%$25.67+240.0%+155.9%$235.28M$2M-4.138Gap UpSOPHSOPHiA GENETICS2.7439 of 5 stars$3.49+0.6%$8.00+129.2%-7.8%$234.50M$65.17M-7.93520AARDAardvark TherapeuticsN/A$10.44-3.2%$32.80+214.2%N/A$233.89MN/A0.0018FENCAdherex Technologies1.9151 of 5 stars$8.20-1.9%$13.33+62.6%+59.4%$232.52M$47.54M-19.5210Analyst RevisionTLSATiziana Life Sciences0.6947 of 5 stars$1.89-4.1%N/A+49.2%$230.19MN/A0.008Positive NewsGALTGalectin Therapeutics2.4068 of 5 stars$3.90+9.2%$6.00+53.8%+51.9%$228.70MN/A-6.099ALECAlector4.0663 of 5 stars$2.13-5.3%$4.17+95.6%-54.6%$227.73M$100.56M-1.84270News CoveragePositive NewsTVRDTvardi Therapeutics1.5629 of 5 stars$24.74+3.1%$64.25+159.7%N/A$224.66M$7.14M0.0080Gap DownMNPRMonopar Therapeutics2.6884 of 5 stars$34.26-4.1%$60.00+75.1%+1,350.4%$220.33MN/A-10.2910Trending NewsAnalyst ForecastAnalyst RevisionCRGXCARGO Therapeutics2.0443 of 5 stars$4.47-1.5%$15.40+244.5%N/A$219.57MN/A-0.96116High Trading Volume Related Companies and Tools Related Companies SGMT Alternatives SOPH Alternatives AARD Alternatives FENC Alternatives TLSA Alternatives GALT Alternatives ALEC Alternatives TVRD Alternatives MNPR Alternatives CRGX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADVM) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adverum Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access